BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8234858)

  • 1. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma.
    Sakamaki H; Onozawa Y; Yano Y; Imai K; Sasaki T; Ibuka T; Funada N; Matsuda T
    Radiat Med; 1993; 11(4):146-53. PubMed ID: 8234858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate-related leukoencephalopathy without radiation therapy: distribution of brain lesions and pathological heterogeneity on two autopsy cases.
    Matsubayashi J; Tsuchiya K; Matsunaga T; Mukai K
    Neuropathology; 2009 Apr; 29(2):105-15. PubMed ID: 18627488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.
    Pande AR; Ando K; Ishikura R; Nagami Y; Ogawa M; Kamikonya N; Kaneda Y; Tanizawa T; Nakao N
    Radiat Med; 2006 Aug; 24(7):515-9. PubMed ID: 17058146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of disseminated necrotizing leukoencephalopathy following intrathecal methotrexate in acute lymphocytic leukemia].
    Nakashima A; Morimatsu M; Mukae T; Nagayama K; Nakashima T; Hino Y
    Gan No Rinsho; 1983 Feb; 29(2):A-9, 138-42. PubMed ID: 6576180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
    Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
    J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report.
    Yokoo H; Nakazato Y; Harigaya Y; Sasaki N; Igeta Y; Itoh H
    Acta Neuropathol; 2007 Oct; 114(4):425-30. PubMed ID: 17357801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
    Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of treatment of 112 cases of primary CNS lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
    Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter.
    Laxmi SN; Takahashi S; Matsumoto K; Higano S; Kurihara N; Imaizumi M; Abe K; Itoyama Y; Sakamoto K
    Radiat Med; 1996; 14(6):303-7. PubMed ID: 9132810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system lymphoma in children.
    Porto L; Kieslich M; Schwabe D; Yan B; Zanella FE; Lanfermann H
    Pediatr Hematol Oncol; 2005; 22(3):235-46. PubMed ID: 16020108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
    Shenkier TN; Voss N; Chhanabhai M; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Morris J; O'Reilly SE; Pickles T; Sehn L; Connors JM
    Cancer; 2005 Mar; 103(5):1008-17. PubMed ID: 15651059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
    J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
    Shah GD; Yahalom J; Correa DD; Lai RK; Raizer JJ; Schiff D; LaRocca R; Grant B; DeAngelis LM; Abrey LE
    J Clin Oncol; 2007 Oct; 25(30):4730-5. PubMed ID: 17947720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia.
    Raje NS; Vaidya SJ; Kapoor G; Pai SK; Nair CN; Kurkure PA; Magrath IT; Advani SH
    Indian Pediatr; 1996 Jul; 33(7):556-60. PubMed ID: 8979564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation.
    Shibamoto Y; Hayabuchi N; Hiratsuka J; Tokumaru S; Shirato H; Sougawa M; Oya N; Uematsu Y; Hiraoka M
    Cancer; 2003 Jan; 97(1):128-33. PubMed ID: 12491514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of central nervous system tumors with methotrexate.
    Abelson HT; Kufe DW; Skarin AT; Major P; Ensminger W; Beardsley GP; Canellos GP
    Cancer Treat Rep; 1981; 65 Suppl 1():137-40. PubMed ID: 6976830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue.
    Allen JC; Rosen G; Mehta BM; Horten B
    Cancer Treat Rep; 1980; 64(12):1261-73. PubMed ID: 6970616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.